anti-influenza plasma
Biologicalexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01306773)
Timeline
Indications
Mechanism of action
- Influenza A virusImmunity, passive
Influenza A virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- anti-influenza immune plasma
- anti-influenza ivig
- anti-influenza plasma
- h1n1 convalescent plasma
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02572817 | Phase 3 | Nov 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT02037282 | Phase 1 | Jan 3, 2014 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01052480 | Phase 2 | Dec 1, 2010 | Leidos, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT01306773 | N/A | Dec 1, 2009 | The University of Hong Kong |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 3 | 2010 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 2 | 2010 |
| Leidos | For profit | 1 | 0 | 1 | 2010 |
| The University of Hong Kong | Academic/Hospital | 1 | 1 | 1 | 2009 |
4 organizations
Page 1 / 1